258 related articles for article (PubMed ID: 15201644)
41. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
Turner RC; Cull CA; Frighi V; Holman RR
JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
[TBL] [Abstract][Full Text] [Related]
42. Alternate site glucose testing: a crossover design.
Bennion N; Christensen NK; McGarraugh G
Diabetes Technol Ther; 2002; 4(1):25-33; discussion 45-7. PubMed ID: 12017416
[TBL] [Abstract][Full Text] [Related]
43. Rate of hypoglycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability data.
Qu Y; Jacober SJ; Zhang Q; Wolka LL; DeVries JH
Diabetes Technol Ther; 2012 Nov; 14(11):1008-12. PubMed ID: 23101951
[TBL] [Abstract][Full Text] [Related]
44. Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.
Jin SM; Kim TH; Bae JC; Hur KY; Lee MS; Lee MK; Kim JH
Diabetes Res Clin Pract; 2014 May; 104(2):266-72. PubMed ID: 24630619
[TBL] [Abstract][Full Text] [Related]
45. A comparison of internet monitoring with continuous glucose monitoring in insulin-requiring type 2 diabetes mellitus.
Tildesley HD; Wright AM; Chan JH; Mazanderani AB; Ross SA; Tildesley HG; Lee AM; Tang TS; White AS
Can J Diabetes; 2013 Oct; 37(5):305-8. PubMed ID: 24500556
[TBL] [Abstract][Full Text] [Related]
46. Assessing potential glycemic overtreatment in persons at hypoglycemic risk.
Tseng CL; Soroka O; Maney M; Aron DC; Pogach LM
JAMA Intern Med; 2014 Feb; 174(2):259-68. PubMed ID: 24322626
[TBL] [Abstract][Full Text] [Related]
47. Influence of Fasting Glucose Levels on Achieving Glycemic Target in Individuals with Type 2 Diabetes: a Post Hoc Analysis.
Ma J; Lei M; Li Y; Zhang X; Cui N; Yang W
Adv Ther; 2020 Sep; 37(9):3816-3826. PubMed ID: 32671687
[TBL] [Abstract][Full Text] [Related]
48. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
Vigersky RA; McMahon C
Diabetes Technol Ther; 2019 Feb; 21(2):81-85. PubMed ID: 30575414
[TBL] [Abstract][Full Text] [Related]
49. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.
Abraira C; Duckworth W; McCarren M; Emanuele N; Arca D; Reda D; Henderson W;
J Diabetes Complications; 2003; 17(6):314-22. PubMed ID: 14583175
[TBL] [Abstract][Full Text] [Related]
50. A probabilistic model for predicting hypoglycemia in type 2 diabetes mellitus: The Diabetes Outcomes in Veterans Study (DOVES).
Murata GH; Hoffman RM; Shah JH; Wendel CS; Duckworth WC
Arch Intern Med; 2004 Jul; 164(13):1445-50. PubMed ID: 15249354
[TBL] [Abstract][Full Text] [Related]
51. Frequent Monitoring of Blood Glucose Levels via a Remote Patient Monitoring System Helps Improve Glycemic Control.
Sachmechi I; Salam S; Amini M; Khan R; Spitznogle A; Belen T
Endocr Pract; 2023 Jun; 29(6):441-447. PubMed ID: 36965657
[TBL] [Abstract][Full Text] [Related]
52. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
53. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization.
Hayward RA; Manning WG; Kaplan SH; Wagner EH; Greenfield S
JAMA; 1997 Nov; 278(20):1663-9. PubMed ID: 9388085
[TBL] [Abstract][Full Text] [Related]
54. A comparison of fructosamine and HbA1c for home self-monitoring blood glucose levels in type 2 diabetes.
Chen HS; Chen RL; Chang ZY; Li HD
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Apr; 65(4):151-5. PubMed ID: 12135193
[TBL] [Abstract][Full Text] [Related]
55. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454
[TBL] [Abstract][Full Text] [Related]
56. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.
Heller S; Koenen C; Bode B
Clin Ther; 2009 Oct; 31(10):2086-97. PubMed ID: 19922879
[TBL] [Abstract][Full Text] [Related]
57. Effects of three frequencies of self-monitored blood glucose on HbA1c and quality of life in patients with type 2 diabetes with once daily insulin and stable control: a randomized trial.
Hortensius J; Kleefstra N; Landman GWD; Houweling BT; Groenier KH; van der Bijl JJ; Bilo H
BMC Res Notes; 2018 Jan; 11(1):26. PubMed ID: 29334997
[TBL] [Abstract][Full Text] [Related]
58. Associations between improved glucose control and patient-reported outcomes after initiation of insulin pump therapy in patients with type 2 diabetes mellitus.
Peyrot M; Rubin RR; Chen X; Frias JP
Diabetes Technol Ther; 2011 Apr; 13(4):471-6. PubMed ID: 21355725
[TBL] [Abstract][Full Text] [Related]
59. Clinical characteristics of type 2 diabetic patients on basal insulin therapy with adequate fasting glucose control who do not achieve HbA1c targets.
Mata-Cases M; Mauricio D; Franch-Nadal J
J Diabetes; 2017 Jan; 9(1):34-44. PubMed ID: 26749415
[TBL] [Abstract][Full Text] [Related]
60. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
